212 related articles for article (PubMed ID: 2570008)
21. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs.
Di Mario F; Gottardello L; Germanà B; Dotto P; Grassi SA; Vianello F; Battaglia G; Leandro G; Burra P; Salvagnini M
Ital J Gastroenterol; 1992; 24(3):122-5. PubMed ID: 1348650
[TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy of cimetidine, famotidine, ranitidine, and mylanta in postoperative stress ulcers. Gastric pH control and ulcer prevention in patients undergoing coronary artery bypass graft surgery.
Lamothe PH; Rao E; Serra AJ; Castellano J; Woronick CL; McNicholas KW; Lemole GM
Gastroenterology; 1991 Jun; 100(6):1515-20. PubMed ID: 2019357
[TBL] [Abstract][Full Text] [Related]
23. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
Hamilton MI; Sercombe J; Pounder RE
Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
[TBL] [Abstract][Full Text] [Related]
24. Comparison of gastric mucosal surface pH response times after intravenous administration of histamine2-receptor antagonists.
Katsu K; Yabe S
Clin Ther; 1995; 17(3):433-10. PubMed ID: 7585847
[TBL] [Abstract][Full Text] [Related]
25. Pharmacology of H2-receptor antagonists: an overview.
Schunack W
J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
[TBL] [Abstract][Full Text] [Related]
26. Famotidine: effective treatment of Zollinger-Ellison syndrome.
Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
[TBL] [Abstract][Full Text] [Related]
27. [Cimetidine versus ranitidine in the treatment of peptic esophagitis].
Noya G; Dettori G; Muscas A; Spirito R; Niolu P; Marongiu G; Biglioli P
Minerva Med; 1983 Apr; 74(14-15):787-90. PubMed ID: 6132354
[TBL] [Abstract][Full Text] [Related]
28. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
Campoli-Richards DM; Clissold SP
Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
[TBL] [Abstract][Full Text] [Related]
29. Clinical importance of the new H2-antagonists.
Walt RP
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():97-9. PubMed ID: 2566730
[TBL] [Abstract][Full Text] [Related]
30. [The effect of histamine H2 receptor blockers on reparative processes in the gastric mucosa of patients with gastric peptic ulcer].
Alekseenko SA; Timoshin SS
Ter Arkh; 1999; 71(2):23-6. PubMed ID: 10222548
[TBL] [Abstract][Full Text] [Related]
31. What are the differences between the H2-receptor antagonists?
Schunack W
Aliment Pharmacol Ther; 1987; 1 Suppl 1():493S-503S. PubMed ID: 2908767
[TBL] [Abstract][Full Text] [Related]
32. Gastric and esophageal acidity during continuous treatment with H2-antagonists in uncomplicated esophagitis.
Fiorucci S; Santucci L; Perrone E; Abbritti F; Morelli A
Scand J Gastroenterol; 1989 Aug; 24(6):671-7. PubMed ID: 2573143
[TBL] [Abstract][Full Text] [Related]
33. Treatment of reflux oesophagitis with H2-receptor antagonists.
Meuwissen SG; Klinkenberg-Knol EC
Scand J Gastroenterol Suppl; 1988; 146():201-13. PubMed ID: 2906465
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
35. New H2-blockers: does more choice help?
Drug Ther Bull; 1988 Aug; 26(17):65-6. PubMed ID: 3138097
[No Abstract] [Full Text] [Related]
36. Omeprazole is more effective than a histamine H2-receptor blocker for maintaining a persistent elevation of gastric pH after colon resection for cancer.
Hsu TC; Su CF; Leu SC; Huang PC; Wang TE; Chu CH
Am J Surg; 2004 Jan; 187(1):20-3. PubMed ID: 14706580
[TBL] [Abstract][Full Text] [Related]
37. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
Bianchi Porro G
Digestion; 1985; 32 Suppl 1():62-9. PubMed ID: 2866137
[TBL] [Abstract][Full Text] [Related]
38. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
Kamada T; Hata J; Kusunoki H; Sugiu K; Ito M; Tanaka S; Kawamura Y; Chayama K; Haruma K
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():99-104. PubMed ID: 15943855
[TBL] [Abstract][Full Text] [Related]
39. Famotidine: clinical applications of a new H2-receptor antagonist. May 16, 1986, Carmel, California.
Am J Med; 1986 Oct; 81(4B):1-64. PubMed ID: 2877568
[No Abstract] [Full Text] [Related]
40. Effect of acid inhibition on Campylobacter pylori.
Blanco M; Pajares JM; Jimenez ML; Lopez-Brea M
Scand J Gastroenterol Suppl; 1988; 142():107-9. PubMed ID: 2901784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
